# Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins

> **NCT01563874** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 130 (actual)

## Conditions studied

- Lymphoma
- Lymphoid Hyperplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01563874
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01563874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01563874, "Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01563874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*